These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 22446634

  • 1. Immunization with high epitope density of M2e derived from 2009 pandemic H1N1 elicits protective immunity in mice.
    Zhou C, Zhou L, Chen YH.
    Vaccine; 2012 May 14; 30(23):3463-9. PubMed ID: 22446634
    [Abstract] [Full Text] [Related]

  • 2. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC.
    Vaccine; 2011 Jul 26; 29(33):5481-7. PubMed ID: 21664216
    [Abstract] [Full Text] [Related]

  • 3. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
    Ebrahimi SM, Dabaghian M, Tebianian M, Jazi MH.
    Virology; 2012 Aug 15; 430(1):63-72. PubMed ID: 22595444
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, Jacobs A, Tang J, McDonald W, Song L, Evans RK, Umlauf S, Tussey L, Powell TJ.
    Vaccine; 2008 Jan 10; 26(2):201-14. PubMed ID: 18063235
    [Abstract] [Full Text] [Related]

  • 6. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
    Tsybalova LM, Stepanova LA, Kuprianov VV, Blokhina EA, Potapchuk MV, Korotkov AV, Gorshkov AN, Kasyanenko MA, Ravin NV, Kiselev OI.
    Vaccine; 2015 Jun 26; 33(29):3398-406. PubMed ID: 25976545
    [Abstract] [Full Text] [Related]

  • 7. Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.
    Wu F, Yuan XY, Huang WS, Chen YH.
    Vaccine; 2009 Oct 09; 27(43):6095-101. PubMed ID: 19056447
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine.
    Adler-Moore J, Munoz M, Kim H, Romero J, Tumpey T, Zeng H, Petro C, Ernst W, Kosina S, Jimenez G, Fujii G.
    Vaccine; 2011 Jun 15; 29(27):4460-8. PubMed ID: 21545821
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
    Liu W, Zou P, Chen YH.
    Immunol Lett; 2004 May 15; 93(2-3):131-6. PubMed ID: 15158608
    [Abstract] [Full Text] [Related]

  • 11. Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin.
    Liu X, Guo J, Han S, Yao L, Chen A, Yang Q, Bo H, Xu P, Yin J, Zhang Z.
    Vaccine; 2012 Oct 12; 30(46):6527-33. PubMed ID: 22959982
    [Abstract] [Full Text] [Related]

  • 12. The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.
    Zou P, Liu W, Chen YH.
    Int Immunopharmacol; 2005 Apr 12; 5(4):631-5. PubMed ID: 15710332
    [Abstract] [Full Text] [Related]

  • 13. Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA).
    Mu X, Hu K, Shen M, Kong N, Fu C, Yan W, Wei A.
    J Virol Methods; 2016 Feb 12; 228():84-90. PubMed ID: 26615805
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity.
    Liu W, Peng Z, Liu Z, Lu Y, Ding J, Chen YH.
    Vaccine; 2004 Dec 02; 23(3):366-71. PubMed ID: 15530682
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1.
    Tompkins SM, Zhao ZS, Lo CY, Misplon JA, Liu T, Ye Z, Hogan RJ, Wu Z, Benton KA, Tumpey TM, Epstein SL.
    Emerg Infect Dis; 2007 Mar 02; 13(3):426-35. PubMed ID: 17552096
    [Abstract] [Full Text] [Related]

  • 18. [Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics].
    Meshcheriakova IuA, El'darov MA, Migunov AI, Stepanova LA, Repko IA, Kiselev OI, Lomonosov DP, Skriabin KG.
    Mol Biol (Mosk); 2009 Mar 02; 43(4):741-50. PubMed ID: 19807038
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
    Stepanova LA, Kovaleva AA, Potapchuk MV, Korotkov AV, Kupriianov VV, Blokhina EA, Kotliarov RIu, Tsybalova LM.
    Vopr Virusol; 2013 Mar 02; 58(3):21-5. PubMed ID: 24006628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.